Previous Article | Next Article ![]()
Infect. Immun., Jan 1995, 21-26, Vol 63, No. 1
K Hatano, JB Goldberg and GB Pier
Virulent strains of Pseudomonas aeruginosa are either of a nonmucoid,
lipopolysaccharide (LPS)-smooth or mucoid, LPS-rough phenotype, and
immunity to these different variants is efficiently mediated by antibodies
specific to O antigens or mucoid exopolysaccharide (also called alginate),
respectively. In addition to O side chains and core polysaccharide
components, the LPS of P. aeruginosa also contains neutral-polysaccharide
components that express antigenic determinants common to many clinical
isolates. We evaluated antibodies specific to neutral polysaccharides for
the ability to mediate opsonic killing and protective immunity. Antibodies
to these antigens mediated opsonic killing of poorly virulent nonmucoid
LPS-rough isolates but not of isogenic strains with either a LPS-smooth or
a mucoid phenotype. Antibodies to neutral-polysaccharide antigens also
failed to protect neutropenic mice from challenge with modest doses of
LPS-smooth P. aeruginosa strains (< 10(3) CFU per mouse), whereas
O-antigen-specific antibodies were highly protective. Antibodies to neutral
polysaccharides deposited significantly (P = 0.002) more C3 onto LPS- rough
strains than did antibodies to O side chains, but this situation was
reversed when isogenic LPS-smooth strains were tested. Given that
protective immunity against P. aeruginosa must be directed against either
nonmucoid LPS-smooth strains or mucoid LPS-rough strains, it appears that
antibodies specific to neutral-polysaccharide antigens do not protect
against P. aeruginosa infection. Lack of protection is likely due to the
ability of both O side chains and mucoid exopolysaccharide (alginate) to
interfere with the opsonic killing activity of
neutral-polysaccharide-specific antibodies.
Copyright © 1995, American Society for Microbiology
Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate)
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|